Clovis Oncology to Announce Third Quarter 2019 Financial Results and Host Webcast Conference Call on November 7
October 22 2019 - 8:30AM
Business Wire
Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its third
quarter 2019 financial results on Thursday, November 7, 2019,
before the open of the U.S. financial markets. Clovis’ senior
management will host a conference call and live audio webcast at
8:30 a.m. ET to discuss the company’s results in greater
detail.
The conference call is being webcast and can be accessed from
the Clovis Oncology website at www.clovisoncology.com. A replay of
the webcast will be available for 30 days.
Conference Call Details
Clovis will hold a conference call to discuss third quarter 2019
results on Thursday, November 7 at 8:30 a.m. ET. The conference
call will be simultaneously webcast on the Company’s web site at
www.clovisoncology.com, and archived for future review. Dial-in
numbers for the conference call are as follows: US participants
(866) 393-4306, International participants (734) 385-2616,
conference ID: 5045559.
About Clovis Oncology
Clovis Oncology, Inc. is a biopharmaceutical company focused on
acquiring, developing and commercializing innovative anti-cancer
agents in the U.S., Europe and additional international markets.
Clovis Oncology targets development programs at specific subsets of
cancer populations, and simultaneously develops, with partners,
diagnostic tools intended to direct a compound in development to
the population that is most likely to benefit from its use. Clovis
Oncology is headquartered in Boulder, Colorado; please visit
www.clovisoncology.com for more information, including additional
office locations in the U.S. and Europe.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191022005145/en/
Clovis Investor Contacts: Anna Sussman 303.625.5022
asussman@clovisoncology.com Breanna Burkart 303.625.5023
bburkart@clovisoncology.com
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Clovis Oncology (NASDAQ:CLVS)
Historical Stock Chart
From Sep 2023 to Sep 2024